The Global Pharmacovigilance Market is on a resilient growth trajectory as healthcare systems worldwide prioritize drug safety and regulatory compliance. According to industry projections, the pharmacovigilance market is expected to expand at a CAGR of 6.6% from 2025 to 2031 , reflecting the increasing scope of drug safety monitoring alongside rapidly evolving regulatory demands. The...
The science of drug safety and pharmacovigilance has become a cornerstone of the clinical research ecosystem in the GCC during the latter half of 2025, with Functional Service Providers playing a vital role in continuous risk assessment. As more multinational pharmaceutical entities conduct multicenter trials in the region, the need for a unified approach to adverse event reporting and safety...